Abivax S.A. Increase Decrease In Cash And Cash Equivalents
Abivax S.A. (ABVX) reported Increase Decrease In Cash And Cash Equivalents of EUR 372.46 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-03-23
- Abivax S.A. increase decrease in cash and cash equivalents for the quarter ending 2025-12-31 was -73.02M EUR.
- Abivax S.A. increase decrease in cash and cash equivalents for the quarter ending 2025-09-30 was 528.76M EUR.
- Abivax S.A. increase decrease in cash and cash equivalents for the quarter ending 2025-06-30 was -42.63M EUR.
- Abivax S.A. increase decrease in cash and cash equivalents for the quarter ending 2025-03-31 was -40.65M EUR.
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|---|---|
| 2025-12-31 | -73.02M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 455.74M EUR derived: sum of 2 quarters · filed 2026-03-23 | 413.11M EUR derived: sum of 3 quarters · filed 2026-03-23 | 372.46M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 528.76M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 486.13M EUR derived: sum of 2 quarters · filed 2025-12-15 | 445.48M EUR 6-K · filed 2025-12-15 | 409.25M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | -42.63M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | -83.28M EUR 6-K · filed 2025-09-08 | -119.50M EUR derived: sum of 3 quarters · filed 2026-03-23 | -161.37M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | -40.65M EUR 6-K · filed 2025-06-02 | -76.88M EUR derived: sum of 2 quarters · filed 2026-03-23 | -118.74M EUR derived: sum of 3 quarters · filed 2026-03-23 | -138.03M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | -36.23M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | -78.09M EUR derived: sum of 2 quarters · filed 2026-03-23 | -97.39M EUR derived: sum of 3 quarters · filed 2026-03-23 | -107.72M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | -41.87M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | -61.16M EUR derived: sum of 2 quarters · filed 2025-12-15 | -71.49M EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | -19.29M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | -29.63M EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | -10.33M EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | 224.99M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | -33.75M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | 31.40M EUR 20-F · filed 2024-04-05 |